HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease.

Abstract
Alpha-synuclein (α-syn) aggregation is the hallmark pathological lesion in brains of patients with Parkinson's disease (PD) and related neurological disorders characterized as synucleinopathies. Accumulating evidence now indicates that α-syn deposition is also present within the gut and other peripheral organs outside the central nervous system (CNS). In the current study, we demonstrate for the first time that α-syn pathology also accumulates within the liver, the main organ responsible for substance clearance and detoxification. We further demonstrate that cultured human hepatocytes readily internalize oligomeric α-syn assemblies mediated, at least in part, by the gap junction protein connexin-32 (Cx32). Moreover, we identified a time-dependent accumulation of α-syn within the liver of three different transgenic (tg) mouse models expressing human α-syn under CNS-specific promoters, despite the lack of α-syn mRNA expression within the liver. Such a brain-to-liver transmission route could be further corroborated by detection of α-syn pathology within the liver of wild type mice one month after a single striatal α-syn injection. In contrast to the synucleinopathy models, aged mice modeling AD rarely show any amyloid-beta (Aß) deposition within the liver. In human post-mortem liver tissue, we identified cases with neuropathologically confirmed α-syn pathology containing α-syn within hepatocellular structures to a higher degree (75%) than control subjects without α-syn accumulation in the brain (57%). Our results reveal that α-syn accumulates within the liver and may be derived from the brain or other peripheral sources. Collectively, our findings indicate that the liver may play a role in the clearance and detoxification of pathological proteins in PD and related synucleinopathies.
AuthorsJuan F Reyes, Sara Ekmark-Léwen, Marina Perdiki, Therése Klingstedt, Alana Hoffmann, Emilia Wiechec, Per Nilsson, K Peter R Nilsson, Irina Alafuzoff, Martin Ingelsson, Martin Hallbeck
JournalActa neuropathologica communications (Acta Neuropathol Commun) Vol. 9 Issue 1 Pg. 46 (03 20 2021) ISSN: 2051-5960 [Electronic] England
PMID33743820 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • SNCA protein, human
  • alpha-Synuclein
Topics
  • Aged
  • Aged, 80 and over
  • Animals
  • Brain (metabolism, pathology)
  • Disease Models, Animal
  • Female
  • Humans
  • Lewy Body Disease (metabolism, pathology, physiopathology)
  • Liver (metabolism)
  • Male
  • Mice
  • Mice, Transgenic
  • Microscopy, Electron, Transmission
  • Parkinson Disease (metabolism, pathology, physiopathology)
  • Synucleinopathies (metabolism, pathology, physiopathology)
  • alpha-Synuclein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: